Unique ID issued by UMIN | UMIN000020275 |
---|---|
Receipt number | R000023406 |
Scientific Title | Bleeding events of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients. |
Date of disclosure of the study information | 2015/12/19 |
Last modified on | 2019/02/14 08:38:50 |
Bleeding events of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients.
Bleeding events of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients.
Bleeding events of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients.
Bleeding events of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients.
Japan |
Venous thromboembolism
Cardiology |
Others
NO
The purpose of this study is to reveal the safety of direct oral anti-coagulant for treatment of venous thromboembolism in advanced cancer patients.
Safety
The primary endpoint is the incidence of bleeding during the 12 weeks of treatment of venous thromboembolism with direct oral anti-coagulant.
The secondary endpoint is the incidence of adverse events during the 12 weeks of treatment of thromboembolism with direct oral anti-coagulant.
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)Pathologically confirmation of cancer.
2)Advanced cancer patients.
3)Deep venous thrombosis and/or plumonary embolism.
4)Thrombus documented by contrast enhanced CT or ultrasonography.
5)Direct oral anti-coagulant is planned.
6)Written informed consent.
1)Other anti-coagulant or anti-platelet is administered.
2)Other disease requiring anti-coagulant therapy.
3)History of intracranial bleeding.
4)Active bleeding.
5)Thrombolytic therapy is planned.
6)Renal failure (Cre>=1.5mg/dL)
7)Platelet count <100,000/mm3
147
1st name | |
Middle name | |
Last name | Takuya Oyakawa |
Shizuoka Cancer Center
Cardiology
1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan
(+81)055-989-5222
t.oyakawa@scchr.jp
1st name | |
Middle name | |
Last name | Takuya Oyakawa |
Shizuoka Cancer Center
Cardiology
1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan
(+81)055-989-5222
t.oyakawa@scchr.jp
Shizuoka Cancer Center
Shizuoka Cancer Center
Other
NO
2015 | Year | 12 | Month | 19 | Day |
Published
Completed
2015 | Year | 11 | Month | 11 | Day |
2015 | Year | 12 | Month | 18 | Day |
Prospective observational study.
After December 2015, the patients who meet inclusion criteria are enrolled.
We check adverse events of direct oral anti-coagulant.
2015 | Year | 12 | Month | 19 | Day |
2019 | Year | 02 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023406
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |